Tempus AI Shares Are Trading Higher After the Company Announced It Received U.S. FDA 510(k) Clearance for Tempus ECG-AF Device That Uses AI to Help Identify Patients Who May Be at Increased Risk of Atrial Fibrillation/flutter
Tempus人工智能股票正在上漲，因爲該公司宣佈其Tempus ECG-AF設備獲得了美國FDA 510(k)許可，該設備使用人工智能幫助識別可能處於房顫/房撲危險增加風險的患者。
